December 2023

SHANGHAI, Dec. 14, 2023 /PRNewswire/ — The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced today that it will invest approximately US$3.3 million (approximately 500 million yen[1]) in a global multicenter Phase III clinical trial project (the “Program”) l

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: